Bausch Health Companies | Acreedores Comerciales



Trade Creditors Cambio Fecha
Amgen USD 1.91B 239M 2024-12
ANI Pharmaceuticals USD 45.66M 15.23M 2024-12
Aurora Cannabis CAD 29.52M 20.78M 2024-12
Bausch Health Companies USD 667M 88M 2024-09
Biogen USD 424.2M 1.5M 2024-12
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Canopy Growth CAD 25.49M 50.74M 2024-06
Corcept Therapeutics USD 15.38M 3.21M 2024-12
Danaher USD 1.75B 157M 2024-12
Drreddys Laboratories INR 36.02B 246M 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Gilead Sciences USD 833M 70M 2024-12
Novo Nordisk 24.08B 5.68B 2024-09
Pacira USD 19.13M 234K 2024-12
Perrigo USD 495.2M 36.7M 2024-12
Prestige Brands USD 19.51M 11.67M 2024-12
Supernus Pharmaceuticals USD 4.59M 1.8M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12
Zoetis USD 433M 29M 2024-12



Bausch Health Companies Acreedores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.